RUSSO, FRANCESCO PAOLO
 Distribuzione geografica
Continente #
EU - Europa 537
NA - Nord America 423
AS - Asia 88
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.049
Nazione #
US - Stati Uniti d'America 422
PL - Polonia 351
IT - Italia 52
SE - Svezia 52
IE - Irlanda 42
CN - Cina 27
HK - Hong Kong 25
VN - Vietnam 20
RU - Federazione Russa 13
SG - Singapore 10
BG - Bulgaria 5
GB - Regno Unito 5
BE - Belgio 4
JO - Giordania 4
CZ - Repubblica Ceca 3
DE - Germania 3
ES - Italia 2
KR - Corea 2
NL - Olanda 2
UA - Ucraina 2
CA - Canada 1
EU - Europa 1
FI - Finlandia 1
Totale 1.049
Città #
Warsaw 350
Fairfield 75
Dublin 42
Ashburn 35
Woodbridge 35
Chandler 33
Cambridge 31
Houston 29
Seattle 25
Florence 22
Beijing 19
Wilmington 19
Altamura 18
Ann Arbor 18
Dong Ket 18
Lawrence 18
Hong Kong 16
Princeton 11
Buffalo 10
Dearborn 8
Boston 7
Singapore 7
Norwalk 5
Sofia 5
Brussels 4
Medford 4
San Diego 4
Brno 3
Castelliri 3
Grafing 3
Phoenix 3
Barcelona 2
Dronten 2
Kent 2
London 2
Redmond 2
Shanghai 2
Boardman 1
Chicago 1
Chiswick 1
Dalmine 1
Falls Church 1
Hillsboro 1
Laurel 1
Quanzhou 1
Rome 1
Seoul 1
Shenzhen 1
Toronto 1
Trumbull 1
Totale 905
Nome #
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 182
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 173
HepaDisk – A new quality of life questionnaire for HCV patients 120
AISF position paper on HCV in immunocompromised patients 112
Forecasting Hepatitis C liver disease burden on real-life data. Does the hidden iceberg matter to reach the elimination goals? 106
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 88
Treatment of Hepatitis C virus infection in Italy: A consensus report from an expert panel 83
Correction: Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER cohort study (PLoS ONE (2017) 12: 2 (e0172159) DOI: 10.1371/journal.pone.0172159) 75
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 64
Modeling cost-effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real-life cohort 63
Totale 1.066
Categoria #
all - tutte 2.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020266 0 22 17 20 38 30 35 32 25 20 23 4
2020/2021316 11 17 9 60 26 31 26 24 31 52 8 21
2021/202294 11 0 4 7 4 9 9 6 4 5 11 24
2022/2023202 22 43 23 2 8 38 27 16 18 1 3 1
2023/202449 0 8 11 1 4 2 1 16 1 0 3 2
2024/202530 26 4 0 0 0 0 0 0 0 0 0 0
Totale 1.066